Cited by 46Adipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and AdiposityAdipose Tissue and Metabolism

Determinants of Serum Adiponectin in Persons with and without Type 1 Diabetes

Maahs, David M., Ogden, Lorraine G., Snell-Bergeon, Janet K., Kinney, Gregory L., Wadwa, R. Paul, Hokanson, John E., Dabelea, Dana, Kretowski, Adam +2 more·2007·American Journal of Epidemiology

Abstract

Low levels of adiponectin have been related to coronary heart disease, but adiponectin is higher in persons with type 1 diabetes who have an increased rate of coronary disease. In the Coronary Artery Calcification in Type 1 Diabetes Study (2000-2002), the authors investigated potential determinants of elevated adiponectin levels in persons with type 1 diabetes and whether a difference exists compared with nondiabetic persons. Serum adiponectin was measured in 1,393 persons (sex: 48% male; age: 38 (standard deviation: 9) years; diabetes duration: 23 (standard deviation: 9) years; 54% nondiabetic and 46% with type 1 diabetes). Determinants of log-transformed adiponectin levels were evaluated by multiple linear regression analysis with interaction terms to determine whether predictors of adiponectin levels differed by diabetes status. Adiponectin levels were higher in type 1 diabetic than nondiabetic persons (13.5 (standard deviation: 1.0) vs. 8.8 (standard deviation: 1.0) microg/ml; p < 0.0001), adjusting for age, gender, body mass index, and glomerular filtration rate. The final regression model explained 67% of the difference in adiponectin levels between type 1 diabetic and nondiabetic persons. The variables explaining this difference included high density lipoprotein cholesterol, albumin excretion rate, plasminogen activator inhibitor-1, and hemoglobin A1c level. Adiponectin is higher in type 1 diabetic than nondiabetic persons. Although some of the difference can be explained, further study is needed to better understand the relation between elevated adiponectin levels and patient outcomes, including coronary heart disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/aje/kwm125

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Patients with type 1 diabetes have higher than expected adiponectin levels: an observation that is poorly understood.

    “In contrast, patients with type 1 diabetes have higher than expected adiponectin levels: an observation that is poorly understood.66”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Chudek J, Adamczak M, Karkoszka H, et al. Plasma adipo- nectin concentration before and after successful kidney trans- plantation. Transplant Proc 2003;35:2186-9.

Cited by

Sorted by citations

Authors
Maahs, D. M., Ogden, L. G., Snell-Bergeon, J. K., Kinney, G. L., Wadwa, R. P., Hokanson, J. E., Dabelea, D., Kretowski, A., Eckel, R. H., & Rewers, M.
Affiliations
University of Colorado Health (US)
Venue
American Journal of Epidemiology
Published
2007-06-24
Volume
166
Issue
6
Pages
731-740
ISSN
  • 0002-9262 (ISSN-L)
  • 1476-6256
OpenAlex
W2164721123
Cited by
46
References
43
Citations by year
2026: 1 · 2025: 3 · 2023: 2 · 2022: 1 · 2021: 1 · 2019: 1 · 2017: 4 · 2016: 5 · 2015: 5 · 2014: 2 · 2013: 4 · 2012: 4
FWCI
2.52
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Epidemiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (HL61753, R01HL61753, R01HL061753)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057516, P30 DK 57516)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
adiponectin, type 1 diabetes, coronary artery disease, coronary artery calcification, HDL cholesterol, urinary albumin excretion rate, plasminogen activator inhibitor-1, HbA1c, diabetic nephropathy
MeSH terms
Adult, Age Factors, Coronary Disease, Diabetes Mellitus, Type 1, Female, Glomerular Filtration Rate, Humans, Male, Middle Aged, Surveys and Questionnaires, Risk Factors, Sex Factors, Linear Models, Case-Control Studies, Adiponectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review